TRDA Entrada Therapeutics, Inc.

NEUTRAL Impact: 2/10 144
Horizon immediate Filed May 4, 2026 Processed 1mo ago SEC 0001950047-26-004004
Form 144 — notice of proposed sale of securities
Latest settled — T+20d ⚠ clustered
TRDA ▼ -57.84% at T+20d
NEUTRAL call ✗ call lost -57.84% · α vs SPY -62.80% · entry $15.75 → $6.64
Next anchor: T+60d in 7w
Last close $6.26 (close Jun 8) · -60.25% from $15.75 entry
Entry anchored
May 4, 2026
via day open
T+1d
+1.78%
call +1.78% · α +0.39%
$16.03
settled 5w ago
T+5d
-54.79%
call -54.79% · α -56.78%
$7.12
settled 4w ago
T+20d
-57.84%
call -57.84% · α -62.80%
$6.64
settled 8d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Officer Nathan Dowden filed Form 144 to sell 15,000 shares (approx. $217,500) under a 10b5-1 trading plan. The sale is routine and pre-arranged, representing a small fraction of market cap. No material impact expected.

Actionable Insight

Routine insider sale under a pre-arranged 10b5-1 plan with minimal dollar value. No trading action warranted. Monitor any future unplanned insider selling for potential change in sentiment.

Key Facts

  • Officer Nathan Dowden intends to sell 15,000 shares of common stock.
  • Estimated aggregate market value: $217,500.
  • Sale is proposed under a 10b5-1 trading plan, reducing informational content.
  • Shares were acquired via exercise of stock options on same date.
  • Prior 10b5-1 sales occurred in March 2026.

Financial Impact

$217,500 (0.04% of market cap)

dilution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004004
Document: 0001950047-26-004004-index.html0001950047-26-004004
Document: 0001950047-26-004004.txt0001950047-26-004004
7 reports for TRDA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TRDA — sortable, filterable
Type Now
Jun 2, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$6.64 $6.58▼ −0.90%▼ −0.18%$6.26 (−5.72%)
May 7, 2026
4w ago
Press Release
MIXED ★ 6/10
$6.85 $6.84▼ −0.15%▼ −0.98%$6.26 (−8.61%)
May 4, 2026
5w ago
144
NEUTRAL ★ 2/10
$15.75 $16.03▲ +1.78%▲ +0.39%$6.26 (−60.25%)
May 4, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$15.79 $15.75▲ +0.25%▲ +1.05%$6.26 (+60.35%)
Apr 24, 2026
6w ago
DEFA14A
NEUTRAL ★ 3/10
$12.63 $12.96▲ +2.61%▲ +2.45%$6.26 (−50.44%)
Mar 4, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$12.50 $11.62▼ −7.04%▼ −6.47%$6.26 (−49.92%)
Feb 26, 2026
14w ago
8-K
BEARISH ★ 6/10
$12.79 $11.93▲ +6.72%▲ +6.27%$6.26 (+51.06%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 6h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access